Arrowhead CMO sells 10,000 shares at $75
Arrowhead Pharmaceuticals' Chief Medical Officer, James C. Hamilton, sold 10,000 shares of common stock in an open-market transaction at a weighted average price of $75.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Arrowhead Pharmaceuticals' Chief Medical Officer, James C. Hamilton, sold 10,000 shares of common stock in an open-market transaction at a weighted average price of $75.00 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan. Following this sale, Hamilton directly holds 226,958 shares, including shares underlying Restricted Stock Units, some of which remain subject to vesting conditions.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares
Net Sell
1 txn
Insider
Hamilton James C
Role
Chief Medical Officer
Sold
10,000 shs ($750K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $75.00 | $750K |
Holdings After Transaction:
Common Stock — 226,958 shares (Direct)
Footnotes (3)
- F1. Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.13, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- F3. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.
Key Figures
Shares sold: 10,000 shares
Weighted average sale price: $75.00 per share
Post-transaction holdings: 226,958 shares
+1 more
4 metrics
Shares sold
10,000 shares
Open-market sale of common stock
Weighted average sale price
$75.00 per share
Sale executed in multiple transactions
Post-transaction holdings
226,958 shares
Shares directly held after the sale
Price range of trades
$75.00–$75.13 per share
Range of prices for individual sale transactions
Key Terms
Rule 10b5-1 trading plan, weighted average price, Restricted Stock Units
3 terms
Rule 10b5-1 trading plan regulatory
"Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported on Column 4 is the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Restricted Stock Units financial
"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Arrowhead Pharmaceuticals (ARWR) disclose for James C. Hamilton?
Arrowhead Pharmaceuticals reported that Chief Medical Officer James C. Hamilton sold 10,000 shares of common stock. The open-market sale occurred at a weighted average price of $75.00 per share and was executed under a pre-arranged Rule 10b5-1 trading plan.
Was the Arrowhead Pharmaceuticals (ARWR) insider sale made under a Rule 10b5-1 plan?
Yes. The Form 4 states the shares were sold pursuant to a Rule 10b5-1 trading plan. Such plans are pre-arranged under SEC rules and are designed to allow insiders to sell shares according to a predetermined schedule, independent of day-to-day market developments.
What does the weighted average price mean in the Arrowhead (ARWR) Form 4 filing?
The Form 4 reports a weighted average sale price of $75.00 per share. This means the 10,000 shares were sold in multiple trades at prices between $75.00 and $75.13, and the reported figure reflects the average price across those individual transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
